Abstract:The quantitative structure–activity relationship (QSAR) of 32 flavone and isoflavone derivatives with cytotoxicity expressed as pGC50, which is defined as the negative value of the logarithm of necessary molar concentration of this series of compounds to cause 50% growth inhibition against the human cervical epithelioid carcinoma cell line (HeLa), has been studied by using the density functional theory (DFT), molecular mechanics (MM2) and statistical methods. In order to obtain QSAR model with high predictive ability, the original dataset was randomly divided into a training set comprising 26 compounds and a test set comprising the rest 6 compounds. An optimal model for the training set with significant statistical quality (RA2=0.852) and predictive ability (q2=0.818) was established. The same model was further applied to predict pGC50 values of the 6 compounds in the test set, and the resulting predictive correlation coefficient Rpred2 reaches 0.738, further showing that this QSAR model has high predictive ability. It is very interesting to find that the cytotoxicities of these compounds against HeLa appear to be mainly governed by two quantum-chemical factors, i.e., the energy (ELUMO) of the lowest unoccupied molecular orbital (LUMO) and the net charges of C atom at site 6 on aromatic rings (QC6). Here the possible action mechanism of these compounds was analyzed and discussed in detail, in particular, the fact why the flavone derivatives have considerably higher cytotoxicity than isoflavone derivatives was reasonably explained. Based on this QSAR equation, 5 new compounds with higher cytotoxicity have been theoretically designed. Such results can offer useful theoretical references for experimental works.

Quantitative structure-cytotoxicity relationship of anti-HIV 5-phenyl-1-phenylamino-1H-imidazole derivatives]

The Relationship Between Structures and Cytotoxicitives of Flavone Derivatives Against HIV with Quantum- Chemical Descriptors

QSAR Research of Novel Tetrandrine Derivatives Against Human Hepatocellular Carcinoma.

QSAR of 1-cyclopropyl-6-fluoro-7-substituted-1,4-dihydro 4-oxoquinoline-3-carboxylic acids for anti-HIV activity

QSAR of 1-cyclopropyl-6-fluoro-7-substituted-1,4-dihydro-4-oxoquinoline-3-carboxylic acids for anti-HTV activity

QSAR Studies on a Series of 7,8-Dialkyl-1,3-diaminopyrrolo-[3,2-f]quinazolines with Anticancer Activity

QSAR Studies of HEPT Derivatives As HIV-1 Reverse Transcriptase Inhibitors Using Physicochemical Parameters of Substituents

Quantitative Structure-Activity Relationship of IOPY/ISPY Analogues as HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors

Combined molecular docking, molecular dynamics simulation and quantitative structure–activity relationship study of pyrimido[1,2-c][1,3]benzothiazin-6-imine derivatives as potent anti-HIV drugs

QSAR Study of Carboxylic Acid Derivatives As HIV-1 Integrase Inhibitors

Quantitatives Structure-Activity Relationship and Modification of HIV Protease Inhibitors

QSAR Studies of Anti-HIV Drug HEPT Using 3D-Hovaif

Quantitative Structure-Activity Relationships of Hiv-1 Integrase Inhibitors of Dkas

QSAR Models for 2-Amino-6-arylsulfonylbenzonitriles and Congeners HIV-1 Reverse Transcriptase Inhibitors Based on Linear and Nonlinear Regression Methods.

Quantitative Structure-Activity Relationship of Anti-Hiv Integrase and Reverse Transcriptase Inhibitors Using Norm Indexes.

QSAR Studies on the IC50 of a Class of Thiazolidinone/Thiazolide Based Hybrids As Antitrypanosomal Agents

[Quantitative Structure-Activity Relationship Study of Tetrahydroimidazobenzodiazepinone Anti-Hiv Drug Using Three-Dimensional Holographic Vector of Atomic Interaction Field].

Nonnucleoside HIV-1 Reverse Transcriptase Inhibitors Ⅱ 3D-QSAR Study on 6-(1-naphthylmethyl)substituted Thymines

QSAR, Action Mechanism and Molecular Design of Flavone and Isoflavone Derivatives with Cytotoxicity Against HeLa.

Three dimensional quantitative structure-activity relationship of DATA analogues as HIV-1 reverse transcriptase inhibitors

QSAR Studies on 1-Aryl-tetrahydroisoquinoline Analogs As Active Anti-HIV Agents Based on PSO-v-SVM